Literature DB >> 1261880

Immunological studies in patients with Crohn's disease.

B R MacPherson, R J Albertini, W L Beeken.   

Abstract

An investigation of immunological parameters was conducted in 38 patients with Crohn's disease. The immunological tests employed included skin tests with dinitrochlorobenzene and a battery of common skin test antigens, lymphocyte transformation with phytohaemagglutinin and pokeweed mitogen, serum immunoglobulins, and absolute lymphocyte counts. Crohn's disease patients were divided into two groups, those treated with immunosuppressive drugs and those not receiving immunosuppressive medications. The latter group was subdivided into patients with active and inactive disease. Immunosuppressed patients with Crohn's disease did not develop sensitivity to dinitrochlorobenzene and had mildly depressed skin test reactivity to common skin test procedures. Non-immunosuppressed patients with active Crohn's disease also reacted less frequently to common skin test antigens, but 16 of 17 such patients developed sensitivity to dinitrochlorobenzene. Lymphocyte transformation with phytohaemagglutinin and pokeweed mitogen was normal in all groups of patients with Crohn's disease. However, when suboptimal incubation periods were used with phytohaemagglutinin stimulation, there was a significant difference between Crohn's disease patients and controls. Serum immunoglobulin levels and absolute lymphocyte counts were normal in all Crohn's disease patients. We conclude that immunity in Crohn's disease is qualitatively normal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1261880      PMCID: PMC1411086          DOI: 10.1136/gut.17.2.100

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Peripheral blood T and B cells in chronic inflammatory bowel disease.

Authors:  R G Strickland; S Korsmeyer; R D Soltis; I D Wilson; R C Williams
Journal:  Gastroenterology       Date:  1974-10       Impact factor: 22.682

2.  Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease.

Authors:  P Asquith; S C Kraft; R M Rothberg
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

3.  A study of lymphocyte function in Crohn's disease using the mitotic index.

Authors:  D Cave; B N Brooke
Journal:  Br J Surg       Date:  1973-04       Impact factor: 6.939

4.  Lymphocyte transformation and delayed hypersensitivity in Crohn's disease.

Authors:  C Röpke
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

5.  A simplified technique for in vitro studies of lymphocyte reactivity.

Authors:  J L Pauly; J E Sokal
Journal:  Proc Soc Exp Biol Med       Date:  1972-05

6.  Inflammatory bowel disease: lymphocytic responses to nonspecific stimulation in vitro.

Authors:  J Aas; A Huizenga; A D Newcomer; R G Shorter
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

7.  Investigation of the pathogenic mechanisms in regional enteritis with in vitro lymphocyte cultures.

Authors:  K Parent; J Barrett; I D Wilson
Journal:  Gastroenterology       Date:  1971-10       Impact factor: 22.682

8.  A method for dinitrochlorobenzene contact sensitization. A clinicopathological study.

Authors:  W J Catalona; P T Taylor; A S Rabson; P B Chretien
Journal:  N Engl J Med       Date:  1972-02-24       Impact factor: 91.245

9.  Lymphocyte transformation in the mesenteric lymph nodes of patients with Crohn's disease.

Authors:  P J Guillou; T G Brennan; G R Giles
Journal:  Gut       Date:  1973-01       Impact factor: 23.059

10.  The immune competence of patients with inflammatory bowel disease.

Authors:  P M Bolton; S L James; R G Newcombe; R H Whitehead; L E Hughes
Journal:  Gut       Date:  1974-03       Impact factor: 23.059

View more
  11 in total

1.  Evidence for a transmissible factor in Crohn's disease.

Authors:  B J Donnelly; P V Delaney; T M Healy
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

2.  In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD.

Authors:  J J Lyanga; P Davis; A B Thomson
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

3.  Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.

Authors:  J Lyanga; P Davis; A B Thomson
Journal:  West J Med       Date:  1988-04

4.  The effect of azathioprine on cell-mediated immunity (CMI) to Candida albicans in Crohn's disease.

Authors:  G M Gyte; J M Willoughby
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

5.  Immunopathology of ulcerative colitis and Crohn's disease, nonsurgical therapeutic considerations.

Authors:  F Bläker; K H Schäfer
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

6.  Anergy in Crohn's disease--fact or fiction.

Authors: 
Journal:  Br Med J       Date:  1977-01-29

7.  Alteration in T lymphocyte subpopulations in inflammatory bowel disease.

Authors:  R M Victorino; H J Hodgson
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

Review 8.  Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?

Authors:  R G Shorter
Journal:  Gastroenterol Jpn       Date:  1982-10

9.  Crohn disease. Newer aspects of etiology, diagnosis and therapy.

Authors: 
Journal:  West J Med       Date:  1978-05

10.  Isolation and purification of human large bowel mucosal lymphoid cells: effect of separation technique on functional characteristics.

Authors:  P W Bland; E R Richens; D C Britton; J V Lloyd
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.